Georgia BIO

Atlanta, Georgia – October 18, 2024 – The life science landscape continuously evolves, making it critical to stay ahead. The Georgia Life Sciences Summit, held on October 21-22, 2024, at the Sandy Springs Performing Arts Center in Atlanta, Georgia, will bring together a dynamic panel of experts and industry leaders for a state-of-the-category event.

Highlights from the Agenda:

Investor Strategies: Learn from top investors about the best ways to secure funding for early-stage companies.
Regulatory Pathways: Get the latest insights into FDA guidelines on digital health, SaMD, and AI/machine learning in medical devices. This will cover insights on premarket submissions and post-market surveillance.
Non-Dilutive Financing: Discover innovative funding options that allow companies to maintain control while reducing pressure with a focus on non-dilutive financing.
Biomanufacturing Opportunities: Hear from economic and industry leaders about the power of biomanufacturing in creating sustainable products and resilient supply chains and how Georgia is leading the way in clean energy technology manufacturing.
Pediatric Innovation Day and Showcase: Hear groundbreaking ideas and entrepreneurial spirit converge from startups in the field of pediatric healthcare as they showcase their innovative solutions and drive positive change in the industry.

"We are thrilled to host the Georgia Life Sciences Summit once again, bringing together the brightest minds and key players in the industry to discuss the most pressing challenges and exciting opportunities. This year's event promises to be even more impactful as we showcase Georgia's leadership in innovation."

– Maria Thacker-Goethe, President and CEO, Georgia Bio

Featured Speakers:

Emily Blum, MD, Medical Director, Global Center for Medical Innovation
Christopher Houchens, PhD, Director Division of CBRN Medical Countermeasures, BARDA, ASPR, DHHS
Courtney Law, PhD, Vice President, Life Sciences, Commercial Banking, J.P.Morgan
Karin McIntosh, MPharm, RAC, Vice President, Head of Regulatory Affairs, Atomwise
Ajikumar Parayil, Founder & CEO, Manus Bio
David Penake Chief Executive Officer, Saol Therapeutics
Eric Rugart, Founder & Co-Chair, Broad Street Angels
Ronald J. Shebuski, Ph.D., President & CEO, Nytricx, Inc
Barbara Solow, PhD, SVP, Program Management and Contracts, CyanVac

Who Should Attend:

Whether you're a startup or an established company, this event is a must-attend for anyone looking to navigate the evolving investment landscape. Don't miss this chance to gain valuable insights and connect with industry leaders.

About the Summit

Since its beginning in 2001, the Georgia Bio Life Sciences Summit has become a must-attend event for Georgia’s bioscience and medtech community. The Summit provides a forum for professionals from industry, academia, and government to discuss major trends and issues, including topics related to scientific research, product development, financing, business development, and public policy. It is the one time each year that companies and universities have the opportunity to showcase Georgia’s bioscience innovation.

About Georgia Bio

Georgia Bio (GaBio), founded in 1989, is a non-profit, membership-based organization that promotes the interests and growth of the life sciences industry. It is the state’s largest and most influential life sciences advocacy and business leadership organization, which works to improve access to innovative technologies and grow Georgia’s life sciences economy. Members include companies, universities, research institutions, government groups, and other industry associations involved in the discovery and application of life sciences products and related services that improve the health and well-being of people throughout the world.

Unlocking Opportunities: Insights from Industry Leaders